UK markets closed
  • FTSE 100

    6,984.59
    -36.36 (-0.52%)
     
  • FTSE 250

    17,304.11
    -418.72 (-2.36%)
     
  • AIM

    823.27
    -4.62 (-0.56%)
     
  • GBP/EUR

    1.1197
    +0.0088 (+0.79%)
     
  • GBP/USD

    1.0770
    +0.0087 (+0.81%)
     
  • BTC-GBP

    18,680.83
    +903.38 (+5.08%)
     
  • CMC Crypto 200

    459.22
    +0.08 (+0.02%)
     
  • S&P 500

    3,657.14
    +2.10 (+0.06%)
     
  • DOW

    29,230.21
    -30.60 (-0.10%)
     
  • CRUDE OIL

    78.64
    +1.93 (+2.52%)
     
  • GOLD FUTURES

    1,645.10
    +11.70 (+0.72%)
     
  • NIKKEI 225

    26,571.87
    +140.32 (+0.53%)
     
  • HANG SENG

    17,860.31
    +5.17 (+0.03%)
     
  • DAX

    12,139.68
    -88.24 (-0.72%)
     
  • CAC 40

    5,753.82
    -15.57 (-0.27%)
     

Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026

·2-min read

Summary The Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026 gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.

New York, July 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026" - https://www.reportlinker.com/p06103610/?utm_source=GNW


The analyst forecast three different potential scenarios for the future use of COVID-19 vaccines -
- The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
- The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
- In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.

Scope
This report includes -
- Executive Summary
- Disease Overview: History of the outbreak, Etiology and Pathophysiology
- Epidemiology
- Current Vaccination Options: Includes detailed product profiles with SWOT analysis
- Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
- Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
- R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
- Market Outlook

Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06103610/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001